-
1
المؤلفون: Atul Pathak, Franck Sevenier, Olivier Hanon, Laurence Negre-Pages
المساهمون: Simon, Marie Francoise, Service Pharmacologie Clinique [CHU Toulouse], Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Service de gériatrie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), EVIDENCE Based Communication, FOVEA Group, Pharmacologie clinique, Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse], Université Toulouse III - Paul Sabatier ( UPS ), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Descartes - Paris 5 ( UPD5 ) -AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris]
المصدر: Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2007, 21 (2), pp.199-205. ⟨10.1111/j.1472-8206.2006.00465.x⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2007, 21 (2), pp.199-205. ⟨10.1111/j.1472-8206.2006.00465.x⟩
Fundamental & Clinical Pharmacology, 2007, 21 (2), pp.199-205. 〈10.1111/j.1472-8206.2006.00465.x〉مصطلحات موضوعية: Male, MESH: Observation, MESH: Cognition, Blood Pressure, Observation, MESH : Observation, Neuropsychological Tests, 030204 cardiovascular system & hematology, MESH : Multicenter Studies as Topic, MESH : Antihypertensive Agents, MESH: Hypertension, Cognition, 0302 clinical medicine, Multicenter Studies as Topic, MESH : Female, Pharmacology (medical), Longitudinal Studies, Cognitive decline, MESH : Angiotensin II Type 1 Receptor Blockers, MESH: Longitudinal Studies, MESH : Longitudinal Studies, education.field_of_study, MESH: Middle Aged, MESH: Research Design, Imidazoles, MESH : Hypertension, MESH: Neuropsychological Tests, MESH: Blood Pressure, MESH: Thiophenes, Middle Aged, MESH : Research Design, MESH : Neuropsychological Tests, 3. Good health, MESH : Acrylates, MESH: Acrylates, Acrylates, Research Design, MESH : Cognition, MESH: Receptor, Angiotensin, Type 1, MESH : Thiophenes, Hypertension, Cohort, Female, MESH: Imidazoles, medicine.drug, medicine.medical_specialty, MESH : Male, Population, Thiophenes, Receptor, Angiotensin, Type 1, MESH : Imidazoles, MESH : Cognition Disorders, 03 medical and health sciences, Internal medicine, MESH : Blood Pressure, medicine, Humans, MESH : Middle Aged, MESH: Patient Selection, education, Antihypertensive Agents, Pharmacology, MESH: Antihypertensive Agents, MESH : Receptor, Angiotensin, Type 1, MESH: Humans, business.industry, Patient Selection, MESH : Humans, MESH: Angiotensin II Type 1 Receptor Blockers, Eprosartan, MESH : Patient Selection, Angiotensin II, MESH: Male, Surgery, Clinical trial, MESH: Cognition Disorders, Blood pressure, MESH: Multicenter Studies as Topic, Observational study, Cognition Disorders, business, MESH: Female, Angiotensin II Type 1 Receptor Blockers, 030217 neurology & neurosurgery
-
2
المؤلفون: Sacco, Rl, Diener, Hc, Yusuf, S, Cotton, D, Ounpuu, S, Lawton, Wa, Palesch, Y, Martin, Rh, Albers, Gw, Bath, P, Bornstein, N, Chan, Bp, Chen, St, Cunha, L, Dahlöf, B, DE KEYSER, J, Donnan, Ga, Estol, C, Gorelick, P, Gu, V, Hermansson, K, Hilbrich, L, Kaste, M, Lu, C, Machnig, T, Pais, P, Roberts, R, Skvortsova, V, Teal, P, Toni, Danilo, Vandermaelen, C, Voigt, T, Weber, M, Yoon, Bw, Lembo, Giuseppe, Rasura, Maurizia, Sacchetti, Maria Luisa
المساهمون: Faculteit Medische Wetenschappen/UMCG, Gerontology, Department of neurology, University of Miami Leonard M. Miller School of Medicine (UMMSM)-University of Miami [Coral Gables], Universität Duisburg-Essen [Essen], Boehringer Ingelheim GmbH, Boehringer Ingelheim Pharmaceuticals, Population Health Research Institute, McMaster University [Hamilton, Ontario]-Hamilton General Hospital, Boehringer Ingelheim, Boehringer Ingelheim Ltd, Department of biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina [Charleston] (MUSC), Neurology and Neurological Sciences, Stanford University, Stroke Trials Unit, University of Nottingham, UK (UON), Neurology Department, Ichilov Medical Center, Division of Neurology, Department of Medicine, National University Hospital Singapore, Department of Neurology, Chang Gung Memorial Hospital [Taipei] (CGMH), Neurology department, Universidade de Coimbra [Coimbra], Institute of Medicine, Sahlgrenska University Hospital [Gothenburg], University Medical Center Groningen [Groningen] (UMCG), National Stroke Research Institute, University of Melbourne, Neurological Center for Treatment and Research, Department of Neurology and Rehabilitation, University of Illinois System, Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd, Boehringer Ingelheim AB, Helsinki University Central Hospital, Huashan Hospital [Shangai], Saint John's Medical College, Clinical Trials Methodoloy Group, McMaster University [Hamilton, Ontario], Neurology & Neurosurgery Clinic, Russian State Medical University, Department of Medicine, Neurology, Faculty of Medicine, University of British Columbia (UBC), Department of Neurological Sciences, Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Cardiology Department, SUNY Downstate Medical Center, State University of New York (SUNY)-State University of New York (SUNY), Seoul National University Hospital, Service de Neurologie [CHU Limoges], CHU Limoges, Neuroépidémiologie Tropicale et Comparée (NETEC), Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Université de Limoges (UNILIM), Université de Limoges (UNILIM)-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503), Sacco, Rl, Diener, Hc, Yusuf, S, Cotton, D, Ounpuu, S, Lawton, Wa, Palesch, Y, Martin, Rh, Albers, Gw, Bath, P, Bornstein, N, Chan, Bp, Chen, St, Cunha, L, Dahlof, B, DE KEYSER, J, Donnan, Ga, Estol, C, Gorelick, P, Gu, V, Hermansson, K, Hilbrich, L, Kaste, M, Lu, C, Machnig, T, Pais, P, Roberts, R, Skvortsova, V, Teal, P, Toni, D, Vandermaelen, C, Voigt, T, Weberm, Yoon, Bw, Comi, Giancarlo
المصدر: New England Journal of Medicine, 359(12), 1238-1251. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2008, 359 (12), pp.1238-51. ⟨10.1056/NEJMoa0805002⟩مصطلحات موضوعية: Male, Myocardial Infarction, Angiotensin-Converting Enzyme Inhibitors, MESH: Cognition, Brain Ischemia, NON-INFERIORITY TRIALS, 0302 clinical medicine, aspirina, Secondary Prevention, Aspirin, MESH: Middle Aged, MESH: Risk, Hazard ratio, MESH: Disability Evaluation, MESH: Brain Ischemia, Dipyridamole, MESH: Follow-Up Studies, ARTERIAL ORIGIN ESPRIT, General Medicine, RANDOMIZED CONTROLLED-TRIAL, 3. Good health, MESH: Myocardial Infarction, Platelet aggregation inhibitor, Drug Therapy, Combination, MESH: Hemorrhage, medicine.medical_specialty, MESH: Ticlopidine, MESH: Delayed-Action Preparations, MESH: Drug Delivery Systems, MESH: Factor Analysis, Statistical, Hemorrhage, MESH: Drug Administration Schedule, MESH: Stroke, 03 medical and health sciences, MESH: Severity of Illness Index, Humans, Vascular Diseases, ACTIVE CONTROLLED-TRIALS, MESH: Kaplan-Meier Estimate, Aged, ictus, trial clinico, MESH: Humans, Proportional hazards model, MESH: Angiotensin II Type 1 Receptor Blockers, MESH: Retrospective Studies, medicine.disease, MESH: Benzoates, PREVENTION, MESH: International Cooperation, Delayed-Action Preparations, Benzimidazoles, Factor Analysis, Statistical, MESH: Mental Status Schedule, MESH: Female, 030217 neurology & neurosurgery, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Benzoates, MESH: Proportional Hazards Models, DOUBLE-BLIND, MESH: Double-Blind Method, Telmisartan, Stroke, MESH: Aged, MESH: Angiotensin-Converting Enzyme Inhibitors, Middle Aged, Clopidogrel, MESH: Platelet Aggregation Inhibitors, Anesthesia, MESH: Vascular Diseases, Cardiology, Female, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], medicine.drug, Risk, Double-Blind Method, TICLOPIDINE, Internal medicine, medicine, cardiovascular diseases, MESH: Aspirin, Ticlopidine, HIGH-RISK PATIENTS, Proportional Hazards Models, CEREBRAL-ISCHEMIA, business.industry, MESH: Male, MESH: Recurrence, MESH: Drug Therapy, Combination, TRANSIENT ISCHEMIC ATTACK, MESH: Dipyridamole, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, MESH: Benzimidazoles, business, Platelet Aggregation Inhibitors
وصف الملف: application/pdf
-
3
المؤلفون: Marvin A. Konstam, Douglas Gregory, Michael S. Kiernan, Daniela Dobre, Joseph M. Massaro, Faiez Zannad, Patrick Rossignol
المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CardioVascular Clinical Studies Boston, School of Public Health [Boston], Boston University [Boston] (BU), Tufts University School of Medicine [Boston]
المصدر: International Journal of Cardiology
International Journal of Cardiology, Elsevier, 2014, 173 (3), pp.380-387. ⟨10.1016/j.ijcard.2014.02.034⟩مصطلحات موضوعية: Male, Internationality, Hyperkalemia, 030204 cardiovascular system & hematology, MESH: Stroke Volume, Drug Delivery Systems, 0302 clinical medicine, Risk Factors, MESH: Risk Factors, MESH: Losartan, MESH: Renal Insufficiency, MESH: Double-Blind Method, 030212 general & internal medicine, MESH: Incidence, Ejection fraction, Angiotensin Receptor Antagonists, Incidence, Incidence (epidemiology), MESH: Follow-Up Studies, 3. Good health, Losartan, Cardiology, MESH: Hyperkalemia, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, MESH: Drug Delivery Systems, Renal function, Heart failure, 03 medical and health sciences, Double-Blind Method, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Renin–angiotensin system, medicine, Humans, Renal insufficiency, MESH: Humans, business.industry, MESH: Angiotensin II Type 1 Receptor Blockers, Stroke Volume, medicine.disease, MESH: Male, Endocrinology, MESH: Heart Failure, MESH: Internationality, business, Angiotensin II Type 1 Receptor Blockers, MESH: Female, Follow-Up Studies
-
4
المؤلفون: De Man, Frances, Tu, Ly, Handoko, Louis, Rain, Silvia, Ruiter, Gerrina, François, Charlène, Schalij, Ingrid, Dorfmüller, Peter, Simonneau, Gérald, Fadel, Elie, Perros, Frederic, Boonstra, Anco, Postmus, Piet, Van Der Velden, Jolanda, Vonk-Noordegraaf, Anton, Humbert, Marc, Eddahibi, Saadia, Guignabert, Christophe
المساهمون: Department of Pulmonology, Institute of Cardiovascular Research (ICR)-VU University Medical Center [Amsterdam], Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique, Centre Chirurgical Marie Lannelongue (CCML)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Physiology, Marie Curie Joint Research Fellowship - Number MC 1120-2009, Guignabert, Christophe
المصدر: American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2012, 186 (8), pp.780-9. ⟨10.1164/rccm.201203-0411OC⟩مصطلحات موضوعية: MESH: Rats, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, MESH: Monocrotaline, MESH: Proportional Hazards Models, MESH: Renin-Angiotensin System, idiopathic pulmonary arterial hypertension, MESH: Up-Regulation, MESH: Losartan, MESH: Animals, [SDV.BC] Life Sciences [q-bio]/Cellular Biology, renin angiotensin system, MESH: Middle Aged, MESH: Humans, MESH: Hypertension, Pulmonary, MESH: Angiotensin II Type 1 Receptor Blockers, MESH: Myocytes, Smooth Muscle, monocrotaline, MESH: Case-Control Studies, endothelial cells, MESH: Male, smooth muscle cells, MESH: Receptor, Angiotensin, Type 1, MESH: Disease Progression, MESH: Endothelium, Vascular, MESH: Female, MESH: Cells, Cultured
وصف الملف: application/pdf
-
5
المؤلفون: De Man, Frances, Tu, Ly, Handoko, Louis, Rain, Silvia, Ruiter, Gerrina, François, Charlène, Schalij, Ingrid, Dorfmüller, Peter, Simonneau, Gérald, Fadel, Elie, Perros, Frederic, Boonstra, Anco, Postmus, Piet, Van Der Velden, Jolanda, Vonk-Noordegraaf, Anton, Humbert, Marc, Eddahibi, Saadia, Guignabert, Christophe
المساهمون: Department of Pulmonology, Institute of Cardiovascular Research (ICR)-VU University Medical Center [Amsterdam], Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique, Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre chirurgical Marie Lannelongue, Department of Physiology, Marie Curie Joint Research Fellowship - Number MC 1120-2009
المصدر: American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2012, 186 (8), pp.780-9. ⟨10.1164/rccm.201203-0411OC⟩مصطلحات موضوعية: renin angiotensin system, MESH: Middle Aged, MESH: Humans, MESH: Rats, MESH: Hypertension, Pulmonary, MESH: Angiotensin II Type 1 Receptor Blockers, MESH: Myocytes, Smooth Muscle, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, monocrotaline, MESH: Case-Control Studies, endothelial cells, MESH: Male, smooth muscle cells, MESH: Monocrotaline, MESH: Proportional Hazards Models, MESH: Renin-Angiotensin System, MESH: Receptor, Angiotensin, Type 1, idiopathic pulmonary arterial hypertension, MESH: Up-Regulation, MESH: Losartan, MESH: Animals, MESH: Disease Progression, MESH: Endothelium, Vascular, MESH: Female, MESH: Cells, Cultured
-
6
المؤلفون: P E Postmus, Charlene Francois, Gérald Simonneau, Jolanda van der Velden, Saadia Eddahibi, Elie Fadel, Frances S. de Man, Marc Humbert, Anco Boonstra, Christophe Guignabert, Frédéric Perros, M. Louis Handoko, Silvia Rain, Anton Vonk-Noordegraaf, Ly Tu, Gerrina Ruiter, Peter Dorfmüller, Ingrid Schalij
المساهمون: Pulmonary medicine, Physiology, ICaR - Heartfailure and pulmonary arterial hypertension, Department of Pulmonology, Institute of Cardiovascular Research (ICR)-VU University Medical Center [Amsterdam], Hypertension arterielle pulmonaire physiopathologie et innovation thérapeutique, Centre chirurgical Marie Lannelongue-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Physiology, Marie Curie Joint Research Fellowship - Number MC 1120-2009
المصدر: American Journal of Respiratory and Critical Care Medicine, 186(8), 780-789. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, American Thoracic Society, 2012, 186 (8), pp.780-9. ⟨10.1164/rccm.201203-0411OC⟩
de Man, F S, Tu, L, Handoko, M L, Rain, S, Ruiter, G, Francois, C, Schalij, I, Dorfmuller, P, Simonneau, G, Fadel, E, Perros, F, Boonstra, A, Postmus, P E, van der Velden, J, Vonk Noordegraaf, A, Humbert, M, Eddahibi, S & Guignabert, C 2012, ' Dysregulated Renin-Angiotensin-Aldosterone System Contributes to Pulmonary Arterial Hypertension ', American Journal of Respiratory and Critical Care Medicine, vol. 186, no. 8, pp. 780-789 . https://doi.org/10.1164/rccm.201203-0411OCمصطلحات موضوعية: Sympathetic nervous system, Cardiac output, medicine.medical_treatment, 030204 cardiovascular system & hematology, Critical Care and Intensive Care Medicine, MESH: Monocrotaline, MESH: Proportional Hazards Models, 0302 clinical medicine, MESH: Renin-Angiotensin System, idiopathic pulmonary arterial hypertension, MESH: Up-Regulation, MESH: Losartan, MESH: Animals, renin angiotensin system, MESH: Middle Aged, MESH: Myocytes, Smooth Muscle, monocrotaline, MESH: Case-Control Studies, endothelial cells, 3. Good health, smooth muscle cells, medicine.anatomical_structure, Losartan, MESH: Receptor, Angiotensin, Type 1, Cardiology, MESH: Disease Progression, MESH: Endothelium, Vascular, medicine.drug, MESH: Cells, Cultured, Pulmonary and Respiratory Medicine, medicine.medical_specialty, MESH: Rats, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, 03 medical and health sciences, Pneumonectomy, Internal medicine, Renin–angiotensin system, medicine, Lung transplantation, Lung, MESH: Humans, MESH: Hypertension, Pulmonary, business.industry, MESH: Angiotensin II Type 1 Receptor Blockers, medicine.disease, Pulmonary hypertension, MESH: Male, 030228 respiratory system, business, MESH: Female
-
7
المؤلفون: Michael R. Gold, Cecilia Linde, William T. Abraham, Stefano Ghio, Ted Plappert, Martin St. John Sutton, John M. Herre, Christian Hassager, Claude Daubert, Luigi Tavazzi, Laura Scelsi
المساهمون: University of Pennsylvania Medical Center, University of Pennsylvania [Philadelphia], Fondazione IRCCS Policlinico San Matteo [Pavia], Università di Pavia, GVM Hospitals of Care and Research, Service de cardiologie et maladies vasculaires, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-CHU Pontchaillou [Rennes], Division of Cardiovascular Medicine and the Davis Heart and Lung Research Institute, Ohio State University [Columbus] (OSU), Division of cardiology, Medical University of South Carolina [Charleston] (MUSC), Department of Cardiology, Copenhagen University Hospital-Rigshospitalet [Copenhagen], Copenhagen University Hospital, Sentara Norfolk General Hospital, Karolinska Institutet [Stockholm]-Karolinska University Hospital [Stockholm], This study was supported by Medtronic Inc (Minneapolis, Minn) and the Medtronic Bakken Research Center B.V. in Maastricht, Netherlands., REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group, Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes]
المصدر: Circulation
Circulation, American Heart Association, 2009, 120 (19), pp.1858-65. ⟨10.1161/CIRCULATIONAHA.108.818724⟩مصطلحات موضوعية: Male, MESH: Combined Modality Therapy, Heart disease, MESH: Echocardiography, Doppler, Cardiac Volume, medicine.medical_treatment, heart failure, cardiac resynchronization therapy, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, Doppler echocardiography, Severity of Illness Index, ventricular remodeling, MESH: Stroke Volume, Electrocardiography, 0302 clinical medicine, [INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing, Medicine, echocardiography, 030212 general & internal medicine, New York Heart Association Class I, MESH: Treatment Outcome, MESH: Aged, Ejection fraction, MESH: Middle Aged, medicine.diagnostic_test, Cardiac Pacing, Artificial, MESH: Angiotensin-Converting Enzyme Inhibitors, MESH: Adrenergic beta-Antagonists, MESH: Heart Failure, Systolic, Stroke volume, Middle Aged, Combined Modality Therapy, Echocardiography, Doppler, Treatment Outcome, Cardiology, cardiovascular system, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, medicine.medical_specialty, Adrenergic beta-Antagonists, Cardiac resynchronization therapy, MESH: Ventricular Remodeling, MESH: Cardiac Pacing, Artificial, 03 medical and health sciences, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Physiology (medical), Internal medicine, MESH: Severity of Illness Index, Humans, cardiovascular diseases, Ventricular remodeling, Aged, MESH: Humans, business.industry, MESH: Angiotensin II Type 1 Receptor Blockers, MESH: Cardiac Volume, Stroke Volume, medicine.disease, MESH: Male, MESH: Electrocardiography, Heart failure, business, Angiotensin II Type 1 Receptor Blockers, MESH: Female, Heart Failure, Systolic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed0337a29cf9bc3115b58709042e6318
https://hal.archives-ouvertes.fr/hal-00913616/file/Cardiac_Resynchronization_Induces-accepted.pdf -
8
المؤلفون: François Gueyffier, Jean-Michel Achard, Naoyuki Sato, Roxana Oprisiu-Fournier, Adriana Albu, Albert Fournier, Sandra E. Black, Mohamed Temmar, Hakim Mazouz, Olivier Hanon, Régis Bordet, Jean-Marie Serot, Ji-Guang Wang, Olivier Godefroy, Sébastien Faure
المساهمون: Service de médecine interne, département de néphrologie, CHU Amiens-Picardie, Département de gériatrie, Département de neurologie, Homéostasie Cellulaire et Pathologies (HCP), Université de Limoges (UNILIM)-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-CHU Limoges, Département de physiologie, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Cardiodology Center, University of Ghardaia, Medical Clinic 2, Medical Clinic 2 Cluj-Napoca, Département de pharmacologie médicale, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CIC CHU Lyon (inserm), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Shanghai Institute of Hypertension, Center for Epidemiological and Clinical Trials, Riujin Hospital-Shangai University School of Medicine, Department of medicine, neurology division, Sunnybrook Health Sciences Centre, Department of clinical gene therapy, Osaka University [Osaka]-Osaka Graduate school of medecine, Department of geriatric medicine, Osaka University [Osaka]-Osaka Graduate School of medicine
المصدر: Expert Review of Neurotherapeutics
Expert Review of Neurotherapeutics, Expert Reviews (formerly Future Drugs), 2009, 9 (9), pp.1413-31. ⟨10.1586/ern.09.89⟩مصطلحات موضوعية: Dihydropyridines, Angiotensin receptor, medicine.drug_class, [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology, Angiotensin-Converting Enzyme Inhibitors, MESH: Thiazides, Calcium channel blocker, 030204 cardiovascular system & hematology, Pharmacology, Prevention of dementia, Renin inhibitor, Thiazides, 03 medical and health sciences, 0302 clinical medicine, Humans, Medicine, Dementia, Pharmacology (medical), Cognitive decline, Antihypertensive drug, MESH: Dihydropyridines, Antihypertensive Agents, MESH: Antihypertensive Agents, MESH: Humans, business.industry, General Neuroscience, MESH: Angiotensin II Type 1 Receptor Blockers, MESH: Angiotensin-Converting Enzyme Inhibitors, medicine.disease, Angiotensin II, MESH: Dementia, 3. Good health, Neurology (clinical), business, Angiotensin II Type 1 Receptor Blockers, 030217 neurology & neurosurgery
-
9
المؤلفون: Sébastien Faure, Jean-Marie Serot, Jean-Michel Achard, Hakim Mazouz, Mohammed Temmar, Ji-Guang Wang, Olivier Godefroy, Albert Fournier, Adriana Albu, Olivier Hanon, Florent Boutitie, Svend Strandgaard, Sandra E. Black, Roxana Oprisiu-Fournier
المساهمون: Département de gériatrie, CHU Amiens-Picardie, Département de physiologie, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Service de médecine interne, département de néphrologie, Biostatistiques santé, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Homéostasie Cellulaire et Pathologies (HCP), Université de Limoges (UNILIM)-CHU Limoges-Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503), Département de neurologie, AP-HP - Hôpital Cochin Broca Hôtel Dieu [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Cardiodology Center, University of Ghardaia, Medical Clinic 2, Medical Clinic 2 Cluj-Napoca, Nephrology department, Herlev and Gentofte Hospital, Shanghai Institute of Hypertension, Center for Epidemiological and Clinical Trials, Riujin Hospital-Shangai University School of Medicine, Department of medicine, neurology division, Sunnybrook Health Sciences Centre
المصدر: Expert Review of Neurotherapeutics
Expert Review of Neurotherapeutics, 2009, 9 (9), pp.1289-305. ⟨10.1586/ern.09.88⟩
Expert Review of Neurotherapeutics, Expert Reviews (formerly Future Drugs), 2009, 9 (9), pp.1289-305. ⟨10.1586/ern.09.88⟩مصطلحات موضوعية: Angiotensin receptor, [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology, Models, Neurological, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, 030204 cardiovascular system & hematology, Pharmacology, Brain Ischemia, 03 medical and health sciences, 0302 clinical medicine, MESH: Models, Neurological, Renin–angiotensin system, medicine, Humans, Pharmacology (medical), Stroke, Antihypertensive Agents, MESH: Antihypertensive Agents, Angiotensin II receptor type 1, MESH: Humans, biology, business.industry, General Neuroscience, MESH: Angiotensin II Type 1 Receptor Blockers, MESH: Angiotensin-Converting Enzyme Inhibitors, MESH: Brain Ischemia, Angiotensin-converting enzyme, MESH: Blood Pressure, MESH: Cerebrovascular Circulation, medicine.disease, Angiotensin II, 3. Good health, Blood pressure, Cerebrovascular Circulation, biology.protein, Neurology (clinical), Telmisartan, business, Angiotensin II Type 1 Receptor Blockers, 030217 neurology & neurosurgery, medicine.drug
-
10Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case-control study
المؤلفون: Karine Lacut, Aurélien Delluc, Emmanuel Oger, Dominique Mottier, G. Le Gal, Christophe Leroyer, F.Z. Belattar
المساهمون: Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO)-Université de Brest (UBO), Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2010, 24 (2), pp.255-9. ⟨10.1111/j.1472-8206.2009.00752.x⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2010, 24 (2), pp.255-9. ⟨10.1111/j.1472-8206.2009.00752.x⟩مصطلحات موضوعية: Male, Blood Pressure, 030204 cardiovascular system & hematology, MESH: Hypertension, MESH: Venous Thromboembolism, MESH: Aged, 80 and over, 0302 clinical medicine, Risk Factors, MESH: Risk Factors, Surveys and Questionnaires, Odds Ratio, Pharmacology (medical), Antihypertensive drug, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Venous Thromboembolism, MESH: Blood Pressure, Middle Aged, MESH: Case-Control Studies, 3. Good health, Venous thrombosis, Hypertension, Female, medicine.medical_specialty, medicine.drug_class, 03 medical and health sciences, Pharmacotherapy, Internal medicine, medicine, Humans, Risk factor, Antihypertensive Agents, Aged, 030203 arthritis & rheumatology, Pharmacology, MESH: Antihypertensive Agents, MESH: Humans, business.industry, MESH: Questionnaires, MESH: Angiotensin II Type 1 Receptor Blockers, Case-control study, Odds ratio, medicine.disease, Angiotensin II, MESH: Odds Ratio, MESH: Male, Surgery, Blood pressure, Case-Control Studies, business, Angiotensin II Type 1 Receptor Blockers, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Full Text via ClinicalKey 
PDF full text from Publisher